StockData
CVS HEALTH Corp logo

CVS HEALTH Corp (CVS) stock

CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/3012% above fair value
$85.81−2.78 (-3.14%)

Close on Nov 17, 2026Market cap $109.75BP/E 22.8Yield 3.10%

Earnings

Cvs Health's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 9, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$108.40B
Adjusted EPS, Q3 FY2026
$2.09
$1.60 a year earlier
Latest guidance
Issued
Nov 4, 2026 · 4 items

Quarterly results

Revenue and earnings per share from each of Cvs Health's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Feb 9, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 4, 2026before the open$108.40B–$1.68$2.09Release
Q2 FY2026ended Jun 30, 2026Aug 5, 2026before the open$106.10B+7.3%$2.31$2.58Release
Q1 FY2026ended Mar 31, 2026May 6, 2026before the open$100.40B+6.1%$2.30$2.57Release
Q4 FY2025ended Dec 31, 2025Feb 10, 2026before the open$105.70B+8.2%$2.30$1.09Release
Q3 FY2025ended Sep 30, 2025Oct 29, 2025before the open–––$1.60Release
Q2 FY2025ended Jun 30, 2025Jul 31, 2025before the open$98.90B+8.4%$0.80$1.81Release
Q1 FY2025ended Mar 31, 2025May 1, 2025before the open$94.60B+7.0%$1.41$2.25Release
Q4 FY2024ended Dec 31, 2024Feb 12, 2025before the open$97.70B+4.2%$1.30$1.19Release
Q3 FY2024ended Sep 30, 2024Nov 6, 2024before the open$95.40B+6.2%$0.07$1.09Release
Q2 FY2024ended Jun 30, 2024Aug 7, 2024before the open$91.20B+2.6%$1.41$1.83Release
Q1 FY2024ended Mar 31, 2024May 1, 2024before the open$88.40B+3.6%$0.88$1.31Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Cvs Health's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
Total revenuesGAAPFY2026$420.00B–NewNov 4, 2026
Total revenuesFY2026$414.00B$405.00BRaisedAug 5, 2026
GAAP diluted EPSGAAPFY2026$6.98–NewNov 4, 2026
GAAP diluted EPSGAAPFY2026$6.84 – $7.04$6.24 – $6.44RaisedAug 5, 2026
Adjusted EPSnon-GAAPFY2026$8.20–NewNov 4, 2026
Adjusted EPSnon-GAAPFY2026$7.90 – $8.10$7.30 – $7.50RaisedAug 5, 2026
Cash flow from operationsGAAPFY2026$15.50B–NewNov 4, 2026
Cash flow from operationsFY2026$11.50B$9.50BRaisedAug 5, 2026

Guidance vs results

The last range Cvs Health gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025Adjusted EPS$6.55 – $6.65$6.75Σ4QAbove range
Q3 FY2024Adjusted EPS$1.05 – $1.10$1.09Within range
Q3 FY2024EPS (GAAP)$0.03 – $0.08$0.07Within range

Guidance history

Every forecast Cvs Health put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 4, 2026Adjusted EPSFY2026$8.20New
Nov 4, 2026GAAP diluted EPSFY2026$6.98New
Nov 4, 2026Cash flow from operationsFY2026$15.50BNew
Nov 4, 2026Total revenuesFY2026$420.00BNew
Aug 5, 2026Adjusted EPSFY2026$7.90 – $8.10Raised
Aug 5, 2026GAAP diluted EPSFY2026$6.84 – $7.04Raised
Aug 5, 2026Cash flow from operationsFY2026$11.50BRaised
Aug 5, 2026Total revenuesFY2026$414.00BRaised
May 6, 2026Adjusted EPSFY2026$7.30 – $7.50Raised
May 6, 2026GAAP diluted EPSFY2026$6.24 – $6.44Raised
May 6, 2026Cash flow from operationsFY2026$9.50BRaised
May 6, 2026Total revenuesFY2026$405.00BNew
Feb 10, 2026Adjusted EPSFY2026$7.00 – $7.20New
Feb 10, 2026GAAP diluted EPSFY2026$5.94 – $6.14New
Feb 10, 2026cash flow from operationsFY2026$9.00BNew
Oct 29, 2025Adjusted EPSFY2025$6.55 – $6.65Raised
Oct 29, 2025GAAP diluted earnings (loss) per shareFY2025-$0.34 – -$0.24Lowered
Oct 29, 2025cash flow from operationsFY2025$7.50B – $8.00BRaised
Jul 31, 2025Adjusted EPSFY2025$6.30 – $6.40New
Jul 31, 2025GAAP diluted EPSFY2025$3.84 – $3.94New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Adjusted figures

Non-GAAP numbers Cvs Health reports itself, taken from its earnings releases

MeasureQ3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025
Adjusted operating income$4.19B$5.16B$5.15B$2.60B
Adjusted income attributable to CVS Health$2.70B$3.32B$3.29B–
Adjusted EPS$2.09$2.58$2.57$1.09

Read from the company's own earnings releases; hover a figure for the sentence it came from. Companies choose what to leave out of an adjusted number and there is no standard for it, so these are not comparable between companies the way the audited statements are. Margins here are computed from the adjusted revenue of the same period.

Press releases

Releases Cvs Health filed with the SEC as exhibits to Form 8-K or 6-K

  1. Update
  2. Results
  3. Update
  4. Results
  5. Results
  6. Results
  7. Update
  8. News
  9. Results
  10. News
  11. Results
  12. Results
  13. Update
  14. Results
  15. News

See a number that looks wrong?